Abstract
Poly(ɛ-caprolactone) (PCL) microspheres containing taxol were prepared by the solvent evaporation method and tested for angiogenesis inhibition using the chick chorioallantoic membrane (CAM) model. Very high encapsulation efficiencies (95%) for taxol in PCL microspheres were obtained. In vitro release studies showed about 25% of the loaded drug was released in 6 weeks from microspheres containing 5% taxol. Studies with the CAM showed that taxol released from the microspheres induced vascular regression and inhibited angiogenesis.
Similar content being viewed by others
References
Bodmeier R, McGinity JW (1987) The preparation and evaluation of drug containing poly(D,L-lactide) microspheres formed by the solvent evaporation method. Pharm Res 4: 465
Engelberg I, Kohn J (1991) Physico-mechanical properties of degradable polymers used in medical applications. Biomaterials 12: 292
Ichihara T, Sakamoto K, Mori K, Akagi M (1989) Transcatheter arterial chemoembolization therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride. Cancer Res 49: 4357
Izumikawa S, Yoshioka S, Aso Y, Takeda Y (1991) Preparation of poly(l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate. J Controlled Release 15: 133
Kamei S, Okada H, Inoue Y, Yoshika T, Ogawa Y, Toguchi H (1993) Anti-tumor effects of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution. J Pharmacol Exp Ther 264: 469
Lopes NM, Adams EG, Pitts TW, Bhuyan BK (1993) Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 32: 235
Manfredi JJ, Parnes J, Horwitz SB (1982) Taxol binds to cellular microtubules. J Cell Biol 94: 688
Nakamura H, Mitani T, Murakami T, Toru H, Tsuda K, Nakanishi K, Ishida T, Tomoda K, Hori S, Kozuka T, Monden M, Kuroda C (1994) Five year survival after transcatheter chemoembolization for bepatocellular carcinoma. Cancer Chemother Pharmacol [Suppl] 33: S89
Okamoto Y, Konno A, Togawa K, Kato T, Tamakawa Y, Amaro Y (1986) Arterial chemoembolization with cisplatin microcapsules. Br J Cancer 53: 369
Reference deleted
Pitt CG (1990) Poly ɛ-caprolactone and its copolymers. In: Chasin M, Langer R (eds) Biodegradable polymers as delivery systems. Marcel Dekker, New York, p 71.
Pitt CG, Hendren RW, Schindler A, Woodward SC (1984) The enzymatic surface erosion of aliphatic polyesters. J Controlled Release 1: 3
Rowinsky EK, Cazenave LA, Donehower RC (1990) Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 82: 1247
Sato T, Kanke M, Schroeder HG, DeLuca PP (1988) Porous degradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques. Pharm Res 5: 21
Sefton MV, Brown LR, Langer RS (1984) Ethylene-vinyl acetate copolymer microspheres for controlled release of macromolecules. J Pharm Sci 71: 1859
Spenlehauer G, Vert M, Benoit J-P, Chabot F, Veillard M (1988) Biodegradable cisplatin microspheres prepared by the solvent evaporation method: Morphology and release characteristics. J Controlled Release 7: 217
Stearns ME, Wang M (1992) Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. Cancer es 52: 3776
Stracke ML, Soroush M, Liotta CA, Schiffman E (1993) Cytoskeletal agents inhibit motility and adherence of human tumor cells. Kidney Int 43: 151
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dordunoo, S.K., Jackson, J.K., Arsenault, L.A. et al. Taxol encapsulation in poly(ɛ-caprolactone) microspheres. Cancer Chemother. Pharmacol. 36, 279–282 (1995). https://doi.org/10.1007/BF00689043
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00689043